Pfizer has stopped enrolling in the Paxlovid experiment
The study finds drugs not effective in reducing symptoms in standard-risk patients. The drug has emergency use authorization for high-risk groups. Data from Israel shows drug reduces hospitalization and death rates in vaccinated and unvaccinated patients 65 years and older, but was not found to prevent severe illness. Pfizer Inc (PFE.N) said on Tuesday it … Read more
